These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 21920697)

  • 61. The impact of clinical and population strategies on coronary heart disease mortality: an assessment of Rose's big idea.
    Ahmadi M; Lanphear B
    BMC Public Health; 2022 Jan; 22(1):14. PubMed ID: 34991551
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Persistent high heart rate raises mortality rate in CHD patients. A high heart rate in patients with stable coronary heart disease raises the risk of complications even when other factors are under control.
    Heart Advis; 2011 Jan; 14(1):9. PubMed ID: 22973599
    [No Abstract]   [Full Text] [Related]  

  • 63. Population and primary health care characteristics and coronary heart disease mortality.
    Kiran T; Dhalla IA
    JAMA; 2011 Feb; 305(8):778-9; author reply 779. PubMed ID: 21343572
    [No Abstract]   [Full Text] [Related]  

  • 64. Early Death After Chemotherapy as a Quality Indicator-Is It Time to Bench the Benchmark?
    Dunn C; Gately L; Gibbs P
    JAMA Oncol; 2022 Nov; 8(11):1559-1560. PubMed ID: 35980644
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Educating people to the dangers of CHD.
    Nurs Stand; 1991 Apr; 5(28):15. PubMed ID: 27663335
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The pathophysiology of coronary heart disease from a student's perspective.
    White C
    J Perioper Pract; 2016 Jul; 26(7-8):170-173. PubMed ID: 29328757
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Editorial: Novel and potential markers for prediction of outcome in patients with acute and chronic coronary heart disease.
    Ten Cate H; Kontny F; Nilsen DW
    Front Cardiovasc Med; 2019; 6():66. PubMed ID: 31192230
    [No Abstract]   [Full Text] [Related]  

  • 68. Reduction in CHD mortality was explained by both secondary risk factor reduction and improved treatment of CHD.
    Dagenais GR
    Evid Based Cardiovasc Med; 1997 Sep; 1(3):64. PubMed ID: 16379725
    [No Abstract]   [Full Text] [Related]  

  • 69. Better coronary care reduces deaths from heart disease.
    Kmietowicz Z
    BMJ; 2000 Mar; 320(7235):600. PubMed ID: 10698868
    [No Abstract]   [Full Text] [Related]  

  • 70. A Systematic Review and Meta-Analysis of Health Care Quality in Iran Based on the Comprehensive Quality Measurement in Health Care Model.
    Markazi-Moghaddam N; Balaye Jame SZ; Nikoomanesh M; Rezapour R
    Int J Prev Med; 2023; 14():10. PubMed ID: 36942033
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Evidence-based medicine among health-care workers in hospitals in Iran: A nationwide survey.
    Moosavi A; Sadeghpour A; Azami-Aghdash S; Derakhshani N; Mohseni M; Jafarzadeh D; Rezapour A
    J Educ Health Promot; 2020; 9():365. PubMed ID: 33575401
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Decline in Cardiovascular Mortality: Possible Causes and Implications.
    Mensah GA; Wei GS; Sorlie PD; Fine LJ; Rosenberg Y; Kaufmann PG; Mussolino ME; Hsu LL; Addou E; Engelgau MM; Gordon D
    Circ Res; 2017 Jan; 120(2):366-380. PubMed ID: 28104770
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Comparative-effectiveness of revascularization versus routine medical therapy for stable ischemic heart disease: a population-based study.
    Wijeysundera HC; Bennell MC; Qiu F; Ko DT; Tu JV; Wijeysundera DN; Austin PC
    J Gen Intern Med; 2014 Jul; 29(7):1031-9. PubMed ID: 24610309
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Beyond case fatality rate: using potential impact fraction to estimate the effect of increasing treatment uptake on mortality.
    Mitsakakis N; Wijeysundera HC; Krahn M
    BMC Med Res Methodol; 2013 Sep; 13():109. PubMed ID: 24006924
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Achieving quality indicator benchmarks and potential impact on coronary heart disease mortality.
    Wijeysundera HC; Mitsakakis N; Witteman W; Paulden M; van der Velde G; Tu JV; Lee DS; Goodman SG; Petrella R; O'Flaherty M; Capewell S; Krahn M
    Can J Cardiol; 2011; 27(6):756-62. PubMed ID: 21920697
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The population mortality benefits of maximizing the number of eligible patients receiving appropriate cardiology treatments in Ireland.
    Kabir Z; Bennett K; Shelley E; Unal B; Critchley J; Feely J; Capewell S
    QJM; 2006 Aug; 99(8):523-30. PubMed ID: 16861717
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Characteristics and baseline clinical predictors of future fatal versus nonfatal coronary heart disease events in older adults: the Cardiovascular Health Study.
    Pearte CA; Furberg CD; O'Meara ES; Psaty BM; Kuller L; Powe NR; Manolio T
    Circulation; 2006 May; 113(18):2177-85. PubMed ID: 16651468
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Impact of acute beta-blocker therapy for patients with non-ST-segment elevation myocardial infarction.
    Miller CD; Roe MT; Mulgund J; Hoekstra JW; Santos R; Pollack CV; Ohman EM; Gibler WB; Peterson ED
    Am J Med; 2007 Aug; 120(8):685-92. PubMed ID: 17679127
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study.
    Maradit-Kremers H; Crowson CS; Nicola PJ; Ballman KV; Roger VL; Jacobsen SJ; Gabriel SE
    Arthritis Rheum; 2005 Feb; 52(2):402-11. PubMed ID: 15693010
    [TBL] [Abstract][Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.